Phenylalanine
- Generic Name
- Phenylalanine
- Brand Names
- Aminosyn II 7 %, Sulfite-free, Aminosyn-PF 7%, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Freamine 6.9, Freamine III 10, Hepatamine 8, Nephramine, Olimel, Periolimel, Plenamine, Premasol, Primene, Procalamine 3, Prosol, Travasol 10, Trophamine 10 %
- Drug Type
- Small Molecule
- Chemical Formula
- C9H11NO2
- CAS Number
- 63-91-2
- Unique Ingredient Identifier
- 47E5O17Y3R
Overview
Phenylalanine is an essential aromatic amino acid that is a precursor of melanin, dopamine, noradrenalin (norepinephrine), and thyroxine.
Background
Phenylalanine is an essential aromatic amino acid that is a precursor of melanin, dopamine, noradrenalin (norepinephrine), and thyroxine.
Indication
L-phenylalanine may be helpful in some with depression. It may also be useful in the treatment of vitiligo. There is some evidence that L-phenylalanine may exacerbate tardive dyskinesia in some schizophrenic patients and in some who have used neuroleptic drugs.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Kabiven
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAVENOUS
Strength:231 mg in 100 mL
Approved: 2023/08/02
NDC:63323-712
CLINIMIX
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:336 mg in 100 mL
Approved: 2021/04/13
NDC:0338-0198
ProSol
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:1 g in 100 mL
Approved: 2020/10/07
NDC:0338-0499
Travasol
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:560 mg in 100 mL
Approved: 2017/11/16
NDC:0338-0644
Clinisol
Manufacturer:Baxter Healthcare Corporation
Route:INTRAVENOUS
Strength:1.04 g in 100 mL
Approved: 2018/06/01
NDC:0338-0502
Singapore Approved Products
VAMINOLACT INTRAVENOUS SOLUTION
Manufacturer:FRESENIUS KABI AUSTRIA GMBH
Form:INJECTION
Strength:2.7 g/1000 ml
Online:Yes
Approved: 1993/05/12
Approval:SIN07428P
OLICLINOMEL N4-550 E EMULSION FOR INFUSION
Manufacturer:BAXTER SA, Ajinomoto North America Incorporated (Intermediate)
Form:EMULSION
Strength:1.23 g/l
Online:Yes
Approved: 2004/05/06
Approval:SIN12542P
SmofKabiven Emulsion for Infusion
Manufacturer:Fresenius Kabi AB, Fresenius Kabi Austria GmbH
Form:INJECTION, EMULSION
Strength:5.1g /1000ml
Online:Yes
Approved: 2013/01/08
Approval:SIN14286P
AMINOPLASMAL-15% INFUSION
Manufacturer:B BRAUN MELSUNGEN AG
Form:INJECTION
Strength:5.7 g/l
Online:Yes
Approved: 1995/09/14
Approval:SIN08352P
KABIVEN EMULSION FOR INFUSION
Manufacturer:FRESENIUS KABI AB, FRESENIUS KABI AUSTRIA GMBH
Form:INJECTION
Strength:2.3 g/1000 ml
Online:Yes
Approved: 2001/09/04
Approval:SIN11657P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath